The Algernon Value Proposition
-
Advancing new drug treatments for billion dollar global disease markets.
-
Advancing 4 lead compounds that either out performed or matched the gold standard of care treatment or one the leading drugs under development, in repeated animal in vivo studies. See our Pipeline
-
Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.
-
In the planning stages for 4 separate phase II clinical trials.
-
Highly capital efficient business model.
-
Experienced management team & globally recognized medical advisory board.